What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Typhoid Fever

The first-line treatment for typhoid fever is azithromycin 500 mg once daily for 7 days due to its superior efficacy compared to fluoroquinolones, lower risk of clinical failure, shorter hospital stays, and lower risk of relapse compared to ceftriaxone. 1

First-Line Treatment Options

  • Azithromycin is recommended at 20 mg/kg/day (maximum 1g/day) for 7 days as the preferred first-line treatment, particularly in areas with high fluoroquinolone resistance 1
  • For severe cases requiring hospitalization, intravenous ceftriaxone is recommended as initial therapy at 2g IV daily for adults and 50-80 mg/kg/day (maximum 2g/day) for children 2, 3
  • Once clinical improvement occurs with IV therapy, transition to oral therapy (such as azithromycin) may be considered 2

Treatment Selection Based on Resistance Patterns

  • Fluoroquinolones (including ciprofloxacin) should be avoided as empiric therapy for cases originating from South Asia due to high resistance rates (>70% of isolates) 1, 3, 4
  • For fully susceptible strains, fluoroquinolones remain effective alternatives, but resistance testing should confirm sensitivity to nalidixic acid 2, 3
  • In regions with high fluoroquinolone resistance, azithromycin or ceftriaxone should be used as first-line therapy 2, 1

Dosing Guidelines

Azithromycin

  • Adults: 500 mg once daily for 7 days 1
  • Children: 20 mg/kg/day (maximum 1g/day) for 7 days 2, 1

Ceftriaxone

  • Adults: 1-2g IV/IM daily for 5-7 days (some guidelines recommend 14 days to reduce relapse risk) 2, 3
  • Children: 50-80 mg/kg/day IV/IM (maximum 2g/day) for 5-7 days 2

Special Considerations

  • Blood cultures should be obtained before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 2, 3
  • Fever typically resolves within 4-5 days of appropriate therapy, with azithromycin showing faster fever clearance (mean 5.8 days) compared to ceftriaxone (7.1 days) and ciprofloxacin (8.2 days) 1, 5
  • Complications such as gastrointestinal bleeding, intestinal perforation, and typhoid encephalopathy occur in 10-15% of patients, particularly if illness duration exceeds 2 weeks 3

Common Pitfalls to Avoid

  • Relying solely on ciprofloxacin disc testing for antibiotic sensitivity is unreliable; the organism should also be sensitive to nalidixic acid to be considered truly sensitive to fluoroquinolones 3
  • Using fluoroquinolones empirically for cases originating from South Asia despite high resistance rates 1, 4
  • Inadequate treatment duration, which can increase relapse risk 3
  • Assuming previous typhoid vaccination provides complete protection; vaccines offer incomplete protection and do not protect against paratyphoid 3

Treatment Algorithm

  1. For uncomplicated typhoid fever:

    • First choice: Azithromycin 500 mg once daily for 7 days (adults) or 20 mg/kg/day for 7 days (children) 1
    • Alternative: Cefixime 16 mg/kg/day for 14 days 5
  2. For severe cases requiring hospitalization:

    • Initial therapy: Ceftriaxone 2g IV daily (adults) or 50-80 mg/kg/day IV (children) 2, 3
    • Once improved: Transition to oral azithromycin to complete treatment course 2
  3. For fully susceptible strains (confirmed by testing):

    • Fluoroquinolones may be used if sensitivity to both ciprofloxacin and nalidixic acid is confirmed 2, 3

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.